244 related articles for article (PubMed ID: 37084092)
1. Signaling mechanisms involved in the regulation of remyelination in multiple sclerosis: a mini review.
Devanand M; V N S; Madhu K
J Mol Med (Berl); 2023 Jun; 101(6):637-644. PubMed ID: 37084092
[TBL] [Abstract][Full Text] [Related]
2. Nudging oligodendrocyte intrinsic signaling to remyelinate and repair: Estrogen receptor ligand effects.
Khalaj AJ; Hasselmann J; Augello C; Moore S; Tiwari-Woodruff SK
J Steroid Biochem Mol Biol; 2016 Jun; 160():43-52. PubMed ID: 26776441
[TBL] [Abstract][Full Text] [Related]
3. Attempts to Overcome Remyelination Failure: Toward Opening New Therapeutic Avenues for Multiple Sclerosis.
Motavaf M; Sadeghizadeh M; Javan M
Cell Mol Neurobiol; 2017 Nov; 37(8):1335-1348. PubMed ID: 28224237
[TBL] [Abstract][Full Text] [Related]
4. Nogo-A and LINGO-1: Two Important Targets for Remyelination and Regeneration.
Kalafatakis I; Papagianni F; Theodorakis K; Karagogeos D
Int J Mol Sci; 2023 Feb; 24(5):. PubMed ID: 36901909
[TBL] [Abstract][Full Text] [Related]
5. Remyelinating strategies in multiple sclerosis.
Luessi F; Kuhlmann T; Zipp F
Expert Rev Neurother; 2014 Nov; 14(11):1315-34. PubMed ID: 25331418
[TBL] [Abstract][Full Text] [Related]
6. Remyelination in multiple sclerosis: cellular mechanisms and novel therapeutic approaches.
Olsen JA; Akirav EM
J Neurosci Res; 2015 May; 93(5):687-96. PubMed ID: 25287108
[TBL] [Abstract][Full Text] [Related]
7. Loss of Tuberous Sclerosis Complex1 in Adult Oligodendrocyte Progenitor Cells Enhances Axon Remyelination and Increases Myelin Thickness after a Focal Demyelination.
McLane LE; Bourne JN; Evangelou AV; Khandker L; Macklin WB; Wood TL
J Neurosci; 2017 Aug; 37(31):7534-7546. PubMed ID: 28694334
[TBL] [Abstract][Full Text] [Related]
8. Regulation of remyelination in multiple sclerosis.
Hanafy KA; Sloane JA
FEBS Lett; 2011 Dec; 585(23):3821-8. PubMed ID: 21443876
[TBL] [Abstract][Full Text] [Related]
9. Recent Advances on Immunosuppressive Drugs and Remyelination Enhancers for the Treatment of Multiple Sclerosis.
Cadenas-Fernández J; Ahumada-Pascual P; Andreu LS; Velasco A
Curr Pharm Des; 2021 Oct; 27(30):3273-3280. PubMed ID: 33504299
[TBL] [Abstract][Full Text] [Related]
10. Retinoid X receptor gamma signaling accelerates CNS remyelination.
Huang JK; Jarjour AA; Nait Oumesmar B; Kerninon C; Williams A; Krezel W; Kagechika H; Bauer J; Zhao C; Baron-Van Evercooren A; Chambon P; Ffrench-Constant C; Franklin RJM
Nat Neurosci; 2011 Jan; 14(1):45-53. PubMed ID: 21131950
[TBL] [Abstract][Full Text] [Related]
11. The Notch signaling pathway: its role in focal CNS demyelination and apotransferrin-induced remyelination.
Aparicio E; Mathieu P; Pereira Luppi M; Almeira Gubiani MF; Adamo AM
J Neurochem; 2013 Dec; 127(6):819-36. PubMed ID: 24032544
[TBL] [Abstract][Full Text] [Related]
12. A dual effect of ursolic acid to the treatment of multiple sclerosis through both immunomodulation and direct remyelination.
Zhang Y; Li X; Ciric B; Curtis MT; Chen WJ; Rostami A; Zhang GX
Proc Natl Acad Sci U S A; 2020 Apr; 117(16):9082-9093. PubMed ID: 32253301
[TBL] [Abstract][Full Text] [Related]
13. Promoting remyelination in multiple sclerosis: current drugs and future prospects.
Kremer D; Küry P; Dutta R
Mult Scler; 2015 Apr; 21(5):541-9. PubMed ID: 25623245
[TBL] [Abstract][Full Text] [Related]
14. Cell replacement therapy with stem cells in multiple sclerosis, a systematic review.
Christodoulou MV; Petkou E; Atzemoglou N; Gkorla E; Karamitrou A; Simos YV; Bellos S; Bekiari C; Kouklis P; Konitsiotis S; Vezyraki P; Peschos D; Tsamis KI
Hum Cell; 2024 Jan; 37(1):9-53. PubMed ID: 37985645
[TBL] [Abstract][Full Text] [Related]
15. Remyelination in multiple sclerosis: realizing a long-standing challenge.
Aharoni R
Expert Rev Neurother; 2015; 15(12):1369-72. PubMed ID: 26558886
[TBL] [Abstract][Full Text] [Related]
16. Remyelinating Pharmacotherapies in Multiple Sclerosis.
Bove RM; Green AJ
Neurotherapeutics; 2017 Oct; 14(4):894-904. PubMed ID: 28948533
[TBL] [Abstract][Full Text] [Related]
17. Total astragalosides promote oligodendrocyte precursor cell differentiation and enhance remyelination in cuprizone-induced mice through suppression of Wnt/β-catenin signaling pathway.
Yuan J; Xu N; Tao Y; Han X; Yang L; Liang J; Jin H; Zhang X; Wu H; Shi H; Huang F; Wu X
J Ethnopharmacol; 2022 Nov; 298():115622. PubMed ID: 35964820
[TBL] [Abstract][Full Text] [Related]
18. Endogeneous remyelination: findings in human studies.
Kipp M; Victor M; Martino G; Franklin RJ
CNS Neurol Disord Drug Targets; 2012 Aug; 11(5):598-609. PubMed ID: 22583436
[TBL] [Abstract][Full Text] [Related]
19. Fibronectin aggregation in multiple sclerosis lesions impairs remyelination.
Stoffels JM; de Jonge JC; Stancic M; Nomden A; van Strien ME; Ma D; Sisková Z; Maier O; Ffrench-Constant C; Franklin RJ; Hoekstra D; Zhao C; Baron W
Brain; 2013 Jan; 136(Pt 1):116-31. PubMed ID: 23365094
[TBL] [Abstract][Full Text] [Related]
20. Targeting Fibronectin to Overcome Remyelination Failure in Multiple Sclerosis: The Need for Brain- and Lesion-Targeted Drug Delivery.
van Schaik PEM; Zuhorn IS; Baron W
Int J Mol Sci; 2022 Jul; 23(15):. PubMed ID: 35955549
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
